Your Location:
Home >
Browse articles >
Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction
OriginalPaper | Updated:2022-05-13
    • Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction

    • Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction

    • 中国结合医学杂志(英文版)   页码:1-6
    • DOI:10.1007/s11655-022-3676-7    

      中图分类号:

    Scan for full text

  • Yue Chen, Yu-ying Xu, Hai-jun Jiang, 等. Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction[J/OL]. 1-6. DOI: 10.1007/s11655-022-3676-7.

    Yue Chen, Yu-ying Xu, Hai-jun Jiang, et al. Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction[J/OL]. 1-6. DOI: 10.1007/s11655-022-3676-7.

  •  
  •  
FULL TEXT LINK
More>

0

浏览量

0

Downloads

0

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Effect of Jianpi Bushen Sequential Formula on Adjuvant Chemotherapy of Colon Cancer: Study Protocol for a Randomized Controlled Trial

相关作者

暂无数据

相关机构

Department of Oncology, Xiyuan Hospital of China Academy of Chinese Medicine Sciences, Beijing, China;Centre for Evidence-Based Chinese Medicine, Beijing University of traditional Chinese Medicine, Beijing, China;Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA
0